Search icon

AIRIS PHARMACEUTICAL SOLUTIONS, INC.

Company Details

Name: AIRIS PHARMACEUTICAL SOLUTIONS, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 05 Dec 2012 (13 years ago)
Entity Number: 4328629
ZIP code: 14043
County: Erie
Place of Formation: New York
Address: 15 WAYNE STREET, DEPEW, NY, United States, 14043

Shares Details

Shares issued 500

Share Par Value 0

Type NO PAR VALUE

Chief Executive Officer

Name Role Address
JEFFREY M. VAN SPLUNDER Chief Executive Officer 15 WAYNE STREET, DEPEW, NY, United States, 14043

DOS Process Agent

Name Role Address
AIRIS PHARMACEUTICAL SOLUTIONS, INC. DOS Process Agent 15 WAYNE STREET, DEPEW, NY, United States, 14043

History

Start date End date Type Value
2012-12-05 2020-12-01 Address 15 WAYNE STREET, DEPEW, NY, 14043, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
201201061974 2020-12-01 BIENNIAL STATEMENT 2020-12-01
181210006381 2018-12-10 BIENNIAL STATEMENT 2018-12-01
161207006485 2016-12-07 BIENNIAL STATEMENT 2016-12-01
141209006474 2014-12-09 BIENNIAL STATEMENT 2014-12-01
121205000851 2012-12-05 CERTIFICATE OF INCORPORATION 2012-12-05

Trademarks Section

Serial Number:
87334160
Mark:
DIVERTALERT
Status:
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Mark Type:
SERVICE MARK
Application Filing Date:
2017-02-13
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
DIVERTALERT

Goods And Services

For:
Design, upgrading and rental of computer software
First Use:
2017-01-17
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
87790211
Mark:
DIVERTALERT
Status:
Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2018-02-08
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
DIVERTALERT

Goods And Services

For:
Software as a service (SAAS) services featuring software for comprehensive drug regulatory compliance
First Use:
2017-01-17
International Classes:
042 - Primary Class
Class Status:
SECTION 8 - CANCELLED

Date of last update: 26 Mar 2025

Sources: New York Secretary of State